Freshfields served as issuer’s counsel to Zymergen Inc. The IPO values the company in excess of $4 billion. The company sold $575 million of shares of...
Zymergen Inc.’s $4 Billion Initial Public Offering
Agilent’s Acquisition Of Resolution Bioscience
Freshfields advised Agilent (NYSE: A) on its acquisition of Resolution Bioscience. The combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with...